ZA977794B - Treatment of pain. - Google Patents
Treatment of pain.Info
- Publication number
- ZA977794B ZA977794B ZA9707794A ZA977794A ZA977794B ZA 977794 B ZA977794 B ZA 977794B ZA 9707794 A ZA9707794 A ZA 9707794A ZA 977794 A ZA977794 A ZA 977794A ZA 977794 B ZA977794 B ZA 977794B
- Authority
- ZA
- South Africa
- Prior art keywords
- pain
- treatment
- dopa
- antidepressant
- neurotransmitters
- Prior art date
Links
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 2
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 abstract 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 abstract 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 abstract 1
- 229940024606 amino acid Drugs 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 238000011260 co-administration Methods 0.000 abstract 1
- 239000000411 inducer Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002858 neurotransmitter agent Substances 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 229960004799 tryptophan Drugs 0.000 abstract 1
- 229960004441 tyrosine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9617990.8A GB9617990D0 (en) | 1996-08-29 | 1996-08-29 | Treatment of pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA977794B true ZA977794B (en) | 1998-04-17 |
Family
ID=10799070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9707794A ZA977794B (en) | 1996-08-29 | 1997-08-29 | Treatment of pain. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6451788B1 (xx) |
| EP (1) | EP1007053B1 (xx) |
| AT (1) | ATE331521T1 (xx) |
| AU (1) | AU733088B2 (xx) |
| DE (1) | DE69736249T2 (xx) |
| DK (1) | DK1007053T3 (xx) |
| ES (1) | ES2264806T3 (xx) |
| GB (1) | GB9617990D0 (xx) |
| PT (1) | PT1007053E (xx) |
| WO (1) | WO1998008520A1 (xx) |
| ZA (1) | ZA977794B (xx) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9617990D0 (en) * | 1996-08-29 | 1996-10-09 | Scotia Holdings Plc | Treatment of pain |
| EP1067950B1 (en) * | 1998-04-10 | 2008-05-14 | Mayo Foundation For Medical Education And Research | Neo-tryptophan |
| CA2329665C (en) * | 1998-04-24 | 2007-09-04 | Scarista Limited | Treatment of depression and pharmaceutical preparations therefor |
| GB9904252D0 (en) * | 1999-02-24 | 1999-04-21 | Worsley Andrew P | Composition for the treatment of pain |
| US6575147B2 (en) * | 1999-02-25 | 2003-06-10 | Go-Tec | Internal combustion system adapted for use of a dual fuel composition including acetylene |
| GB9906808D0 (en) * | 1999-03-24 | 1999-05-19 | Kilgowan Limited | Formulation for treatment of pain |
| US6759437B2 (en) * | 1999-10-04 | 2004-07-06 | Martin C. Hinz | Comprehensive pharmacologic therapy for treatment of obesity including cysteine |
| US6403657B1 (en) * | 1999-10-04 | 2002-06-11 | Martin C. Hinz | Comprehensive pharmacologic therapy for treatment of obesity |
| GB2355191A (en) * | 1999-10-12 | 2001-04-18 | Laxdale Ltd | Combination formulations for fatigue, head injury and strokes |
| GB0216027D0 (en) | 2002-07-10 | 2002-08-21 | Arachnova Therapeutics Ltd | New therapeutic use |
| US6602911B2 (en) * | 2001-11-05 | 2003-08-05 | Cypress Bioscience, Inc. | Methods of treating fibromyalgia |
| CA2475763A1 (en) * | 2002-02-12 | 2003-08-21 | Cypress Bioscience, Inc. | Methods of treating attention deficit/hyperactivity disorder (adhd) |
| US20090311795A1 (en) * | 2002-03-21 | 2009-12-17 | Hinz Martin C | Bilateral control of functions traditionally regulated by only serotonin or only dopamine |
| US20030181509A1 (en) * | 2002-03-21 | 2003-09-25 | Hinz Martin C. | Serotonin and catecholamine system segment optimization technology |
| US20070293571A1 (en) * | 2006-06-08 | 2007-12-20 | Hinz Martin C | Adminstration of dopa precursors with sources of dopa to effectuate optimal catecholamine neurotransmitter outcomes |
| CA2483093A1 (en) * | 2002-04-24 | 2003-11-06 | Cypress Bioscience, Inc. | Use of milnacipran or a pharmaceutically acceptable salt thereof for treating chronic low back pain |
| NZ536415A (en) * | 2002-05-30 | 2006-10-27 | Neurosearch As | Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| US8134029B2 (en) | 2002-09-16 | 2012-03-13 | Sunovion Pharmaceuticals Inc. | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine |
| JP2006504795A (ja) * | 2002-10-03 | 2006-02-09 | サイプレス バイオサイエンス， インコーポレイテッド | 神経学的障害を処置するための抗うつ剤の投薬量の段階的な漸増ならびに毎日の分割した投薬 |
| CA2516653A1 (en) * | 2003-02-21 | 2004-09-10 | Martin C. Hinz | Serotonin and catecholamine system segment optimization technology |
| WO2004105690A2 (en) * | 2003-05-23 | 2004-12-09 | Cypress Bioscience, Inc. | Treatment of chronic pain associated with drug or radiation therapy |
| JP4638685B2 (ja) * | 2003-06-10 | 2011-02-23 | ハイデルベルガー ドルツクマシーネン アクチエンゲゼルシヤフト | オフセット印刷機による印刷の際に湿し水を調量する方法 |
| GB0313630D0 (en) * | 2003-06-12 | 2003-07-16 | Wwk Trust The | Compositions for the enhanced treatment of depression |
| US7442372B2 (en) | 2003-08-29 | 2008-10-28 | Biomarin Pharmaceutical Inc. | Delivery of therapeutic compounds to the brain and other tissues |
| AU2004291082A1 (en) | 2003-11-13 | 2005-06-02 | The General Hospital Corporation | Methods for treating pain |
| MXPA06005451A (es) | 2003-11-17 | 2007-01-26 | Biomarin Pharm Inc | Metodos y composiciones para el tratamiento de trastornos metabolicos. |
| US8003126B2 (en) | 2004-11-17 | 2011-08-23 | Biomarin Pharmaceutical Inc. | Stable tablet formulation |
| EP1819340A2 (en) * | 2004-12-08 | 2007-08-22 | Biomarin Pharmaceutical Inc. | Methods and compositions for the treatment of pulmonary hypertension of the newborn |
| CN101553217A (zh) | 2005-07-06 | 2009-10-07 | 塞普拉科公司 | 艾司佐匹克隆与反式4－(3,4－二氯苯基)－1,2,3,4－四氢－n－甲基－1－萘胺或反式4－(3,4－二氯苯基)－1,2,3,4－四氢－1－萘胺的组合以及治疗绝经期和心境障碍、焦虑症和认知障碍的方法 |
| EP1930328B1 (en) | 2005-09-28 | 2012-06-13 | Daicel Chemical Industries, Ltd. | Cyano-containing polycyclic esters having lactone skeletons |
| US7994220B2 (en) * | 2005-09-28 | 2011-08-09 | Cypress Bioscience, Inc. | Milnacipran for the long-term treatment of fibromyalgia syndrome |
| JP2009518415A (ja) * | 2005-12-05 | 2009-05-07 | バイオマリン ファーマシューティカル インコーポレイテッド | 疾患の処置のための方法および組成物 |
| US20090306050A1 (en) * | 2006-02-03 | 2009-12-10 | Timothy Dinan | Treatment and prevention of depression with pain, depression secondary to pain, and of neuropathic pain |
| WO2007100718A2 (en) * | 2006-02-24 | 2007-09-07 | Denise Barbut | Neurotensin receptor agonists and opioid receptor agonists |
| AU2007233041B2 (en) | 2006-03-31 | 2013-05-02 | Sepracor Inc. | Preparation of chiral amides and amines |
| CN101484210A (zh) * | 2006-05-31 | 2009-07-15 | 塞普拉科公司 | 用反-4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺及其甲酰胺治疗疼痛病 |
| WO2008089148A1 (en) * | 2007-01-12 | 2008-07-24 | Biomarin Pharmaceutical Inc. | Method of treating a metabolic or neuropsychiatry disorder with a bh4 derivative prodrug |
| US20080220104A1 (en) * | 2007-03-08 | 2008-09-11 | Cappello John V | Compositions for producing satiety |
| CA2682598C (en) | 2007-04-11 | 2016-06-07 | Biomarin Pharmaceutical Inc. | Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
| WO2012054815A1 (en) | 2010-10-22 | 2012-04-26 | Duke University | Slow-release formulations of 5-hydroxytryptophan as an adjunct to pro-serotonergic therapies |
| EA201370171A1 (ru) * | 2011-01-26 | 2014-05-30 | Нико Ворлдвайд, Инк. | Лекарство от головной боли при мигрени |
| US9216178B2 (en) | 2011-11-02 | 2015-12-22 | Biomarin Pharmaceutical Inc. | Dry blend formulation of tetrahydrobiopterin |
| ITUB20153879A1 (it) | 2015-09-24 | 2017-03-24 | Professional Dietetics Spa | Composizioni per il trattamento del dolore in pazienti sottoposti ad artroplastica elettiva |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431670A (en) * | 1980-12-19 | 1984-02-14 | Bernardo Heller | D-Phenylalanine treatment |
| US4652559A (en) * | 1982-08-16 | 1987-03-24 | The Upjohn Company | 2-(Phenylmethylene)cycloalkyl-azetidines |
| US4843071A (en) * | 1986-12-05 | 1989-06-27 | Serotonin Industries Of Charleston | Method and composition for treating obesity, drug abuse, and narcolepsy |
| AU710339B2 (en) | 1994-10-05 | 1999-09-16 | Amarin Neuroscience Limited | Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and possibly a vitamin b12 compound |
| DK0942751T3 (da) | 1996-07-05 | 2002-12-02 | Wwk Trust | Præparater til behandling af perifere nuropatier indeholdende antidepressiver og/eller monoaminoxidase-inhibitorer og/eller vitamin B12 og/eller prekursere til eller inducere af en neurotransmitter |
| GB9617990D0 (en) * | 1996-08-29 | 1996-10-09 | Scotia Holdings Plc | Treatment of pain |
-
1996
- 1996-08-29 GB GBGB9617990.8A patent/GB9617990D0/en active Pending
-
1997
- 1997-08-27 AU AU40253/97A patent/AU733088B2/en not_active Ceased
- 1997-08-27 AT AT97937721T patent/ATE331521T1/de not_active IP Right Cessation
- 1997-08-27 PT PT97937721T patent/PT1007053E/pt unknown
- 1997-08-27 DK DK97937721T patent/DK1007053T3/da active
- 1997-08-27 US US09/242,882 patent/US6451788B1/en not_active Expired - Fee Related
- 1997-08-27 EP EP97937721A patent/EP1007053B1/en not_active Expired - Lifetime
- 1997-08-27 ES ES97937721T patent/ES2264806T3/es not_active Expired - Lifetime
- 1997-08-27 DE DE69736249T patent/DE69736249T2/de not_active Expired - Lifetime
- 1997-08-27 WO PCT/GB1997/002295 patent/WO1998008520A1/en not_active Ceased
- 1997-08-29 ZA ZA9707794A patent/ZA977794B/xx unknown
-
2002
- 2002-08-07 US US10/213,905 patent/US6989380B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69736249D1 (de) | 2006-08-10 |
| US6451788B1 (en) | 2002-09-17 |
| AU733088B2 (en) | 2001-05-03 |
| WO1998008520A1 (en) | 1998-03-05 |
| US6989380B2 (en) | 2006-01-24 |
| ATE331521T1 (de) | 2006-07-15 |
| EP1007053B1 (en) | 2006-06-28 |
| AU4025397A (en) | 1998-03-19 |
| GB9617990D0 (en) | 1996-10-09 |
| DE69736249T2 (de) | 2007-05-24 |
| PT1007053E (pt) | 2006-11-30 |
| DK1007053T3 (da) | 2006-10-30 |
| ES2264806T3 (es) | 2007-01-16 |
| EP1007053A1 (en) | 2000-06-14 |
| US20020187958A1 (en) | 2002-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA977794B (en) | Treatment of pain. | |
| DE69722426D1 (de) | Isobutylgaba und dessen derivate zur schmerzbehandlung | |
| AU1718400A (en) | Method for treating pain | |
| CA2304657A1 (en) | Treatment of conduct disorder | |
| TR199802676A2 (xx) | T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem. | |
| DE69616375D1 (de) | Nicht-allosterische GABA A Agonisten zur Behandlung von Schlafstörungen | |
| GR3036548T3 (en) | Apparatus and method for preparing solid forms with controlled release of the active ingredient | |
| ATE213005T1 (de) | Kontinuierliches polymerisationverfahren von polyamiden | |
| TR200000755T2 (tr) | Karşıt olma-karşı gelme bozukluğunun tedavisi. | |
| DE69715000D1 (de) | Verabreichung von gm-csf zur behandlung der gehirntumoren und verhütung deren wiederauftretens | |
| MY118828A (en) | Substituted amino compounds and their use as substances having an analgesic effect | |
| ZA986363B (en) | Novel method of treatment. | |
| DE69626816D1 (de) | Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren | |
| ZA972345B (en) | Use of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol in treating depressive disorders and bipolar disorders. | |
| DK1143917T3 (da) | Antikonvulsive derivater egnet til behandling af posttraumatisk stresssygdom | |
| AU2949497A (en) | Chiral phenyldihydrofuranones as pde-iv inhibitors | |
| GB9612710D0 (en) | Method of treatment | |
| PL318292A1 (en) | Application of selegyline in treating epileptic seizures | |
| IL130642A0 (en) | N-(pyridinylamino)isoindolines and related compounds | |
| MY132066A (en) | Pyrrolidinylmethylindole salt. | |
| DE69909395D1 (de) | Zusammensetzung mit ketanserin und carnitin zur behandlung von crps | |
| BR0112460A (pt) | Método para tratamento de sépsis | |
| RU96100632A (ru) | Способ лечения импотенции | |
| MX9710075A (es) | Antagonistas melatonina para el tratamiento en la hiperplasia prostatica benigna. | |
| WO1998009665A3 (en) | Iontophoretic method of using phenylephrine to improve the effect of local anesthetics |